VirtualToxLab™ - In silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: A progress report

Altex

Volumn 26, Issue 3, 2009, Pages 167-176

  Vedani, Angelo ^a   Smiesko, Martin ^a   Spreafico, Morena ^a   Peristera, Ourania ^a   Dobler, Max ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

In silico prediction of the toxic (endocrine disrupting) potential; Reduction of animal testing; Toxicity mechanisms; VirtualToxLab

Indexed keywords

BIOLOGICAL PRODUCT; DRUG; ENDOCRINE DISRUPTOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; FACTUAL DATABASE; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

BIOLOGICAL PRODUCTS; DATABASES, FACTUAL; ENDOCRINE DISRUPTORS; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE;

EID: 73949093900     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.2009.3.167     Document Type: Article

References (35)

1. Brunström, B., Broman, D. and Näf, C. (1991). Toxicity and EROD-inducing potency of 24 polycyclic aromatic hydrocarbons (PAHs) in chick embryos. Arch. Toxicol. 65, 485-489.
2. Cronin, M. (2003). A toxic gamble. Chemistry and Industry, 4, 13-14.
3. Death, A. K., McGrath, K. C., Kazlauskas, R. and Handelsmann, D. J. (2004). Tetrahydrogestrinone is a potent androgen and progestin. J. Clin. Endocrinol. Metab. 89, 2494-2500.
4. Fan, E., Zhang, L., Jiang, S. and Bai, Y. (2008). Beneficial effects of resveratrol on arteriosclerosis. J. Med. Food 11, 610-614.
5. Fischer, B. (2000). Receptor-mediated effects of chlorinated hydrocarbons. Andrologia 32, 279-283.
6. Gustaffson, J.A. (1995). Receptor-mediated toxicity. Toxicol. Lett. 135, 465-470.
7. Hampson, A. J. and Grimaldi, M. (2002). 12-hydroxyeicosatetrenoate (12-HETE) attenuates AMPA receptor-mediated neurotoxicity: Evidence for a G-protein coupled HETE receptor. J. Neurosci. 22, 257-264.
8. Hestermann, E. V., Stegemann, J. J. and Hahn, M. E. (2000). Relative contribution of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol. Appl. Pharmacol. 168, 160-172.
9. Lill, M. A., Winiger, F., Vedani, A. and Ernst, B. (2005). Impact of induced fit on the ligand binding to the androgen receptor: A multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals. J. Med. Chem. 48, 5666-5674.
10. Lill, M. A., Vedani, A., Dobler, M. (2004). Raptor - combining dual-shell representation, induced-fit simulation and hydrophobicity scoring in receptor modeling: Application towards the simulation of structurally diverse ligand sets. J. Med. Chem. 47, 6174-6186.
11. Lukasink, K. and Pitkanen, A. (2000). GABA(A)-mediated toxicity of hippocampal neurons in vitro. J. Neurochem. 74, 2445-2454.
12. Mason, G., Sawyer, T., Keys, et al. (1985). Polychlorinated dibenzofurans (PCDFs): Correlation between in vivo and in vitro structure-activity relationships. Toxicology 37, 1-12.
13. Markus, M. A. and Morris, B. J. (2008). Resveratrol in prevention and treatment of common clinical conditions of aging. Clin. Interv. Aging 3, 331-339.
14. Mittendorf, R. (1995). Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero. Teratology 51, 435-445.
15. OECD, 2003. http://webdomino1.oecd.org/comnet/env/models.nsf
16. Oliver, J. D. and Roberts, R. A. (2002). Receptor-mediated hepatocarcinogenesis - role of hepatocyte proliferation and apoptosis. Pharmacol. Toxicol. 91, 1-7.
17. Peristera, O., Spreafico, M., Smisko, M. et al. (in press). Mixed-model QSAR at the human mineralocorticoid receptor: Prediciting binding mode and affinity of anabolic steroids. Toxicol. Lett.
18. Rannug, U., Sjörgren, M., Rannug, A. et al. (1991). Use of artificial intelligence in structure-affinity correlations of 2,3,7,8- tetrachloro-dibenzo-p-dioxin (TCDD) receptor ligands. Carcinogenesis 12, 2007-2015.
19. Rihova, B. (1998). Receptor-mediated targeted drug or toxin delivery. Adv. Drug Deliv. Rev. 29, 273-289.
20. Rocha-Gonzales, H. I., Ambriz-Tututti, M. and Granados-Soto, V. (2008). Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases. CNS Neurosci. Ther. 14, 234-247.
21. Rymer, D. L. and Good, T. A. (2001). The role of protein activation in the toxicity of amyloidogenic Aβ (1- 40), Aβ (25-35), and bovine calcitonin. J. Biol. Chem. 276, 2523-2530.
22. Spreafico, M., Smiesko, M., Lill, M. A. et al. (2009). Mixed-model QSAR at the glucocorticoid receptor: Predicting the binding mode and affinity of psychotropic drugs. ChemMedChem 4, 100-109.
23. US Government (1996a): Safe Drinking Water Act Amendment. Public Law 104-182 (Section 136), http://www.epa.gov.safewater/sdwa/index.html
24. US Government (1996b): Food Quality Protection Act. Public Law 104-170 (Section 408), http://www.fda.gov/opacom/laws/foodqual/fqpatoc.htm
25. Vedani, A., Spreafico, M., Peristera, O. and Smiesko, M. (2008). VirtualToxLab - In silico prediction of the endocrine-disrupting potential of drugs and chemicals. Chimia 5, 322-328.
26. Vedani, A., Zumstein, M., Lill, M. A. and Ernst, B. (2007a). Simulating α/β specificity at the thyroid receptor: Consensus scoring in multidimensional QSAR. ChemMedChem 2, 78-87.
27. Vedani, A., Decloux, A. V., Spreafico, M. and Ernst, B. (2007b). Predicting the toxic potential of drugs and chemicals in silico: A model for the peroxisome proliferator-activated receptor γ. Toxicol. Lett. 173, 17-23.
28. Vedani, A., Dobler, M. and Lill, M. A. (2006). The challenge of predicting drug toxicity in silico. Pharmacol. Toxicol. 99, 195-208.
29. Vedani, A., Dobler, M. and Lill, M. A. (2005a). Virtual test kits for predicting harmful effects triggered by drugs and chemicals mediated by specific proteins. ALTEX 22, 123-134.
30. Vedani, A., Dobler, M. and Lill, M. A. (2005b). Combining protein modeling and 6D-QSAR - Simulating the binding of structurally diverse ligands to the estrogen receptor. J. Med. Chem. 48, 3700-3703.
31. Vedani, A. and Dobler, M. (2002). 5D-QSAR: The key for simulating induced fit? J. Med. Chem. 45, 2139-2149.
32. Vedani, A. and Huhta, D. W. (1991). An algorithm for the systematic solvation of proteins based on the directionality of hydrogen bonds. J. Am. Chem. Soc. 113, 5860-5862.
33. Vedani, A. and Huhta, D. W. (1990). A new force field for modeling metalloproteins. J. Am. Chem. Soc. 112, 4759-4767.
34. Vingtdeux, V., Dreses-Werringloer, U., Zhao, H. et al. (2008). Therapeutic potential of resveratrol in Alzheimer's diseases. BMC Neurosci. 9 (Suppl. 2), 6.
35. White paper on the strategy for a future chemicals policy (2003). Cf. http://europa.eu.int/ comm/environment/chemicals/whitepaper.htm